A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Exclusion Criteria

• •Patients less than 10 kg in weight.
• •Use of any other investigational compounds or participations in another clinical trial within 4 weeks prior to the randomisation/registration.
• •Significant clinical illness within 4 weeks prior to the registration
• •Presence of hepatic diseases or other conditions that could interfere with evaluation of the study as judged by the investigators.
• •Positive for pregnancy test by urinary or lactation for post-menarchal females.
• •Previous total gastrectomy